References
- Luo J, Ye W, Zendehdel K, Adami J, Adami H-O, Boff Etta P, Nyrén O. Oral use of Swedish moist snuff (“snus”) and risk for cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study. Lancet 2007; 369:2015–2020.
- Lunell E, Lunell M. Steady-state nicotine plasma levels following use of four different types of Swedish moist snuff compared with 2-mg Nicorette chewing gum: a crossover study. Nicotine Tob Res 2005; 7:397–403.
- Adrian CL, Ohlin H, Dalhoff K, Jacobsen J. In vivo human buccal permeability of nicotine. Int J Pharm 2005; 311:196–202.
- Dart RC. Medical Toxicology. 3rd ed. Philadelphia, USA: Lippincott Williams & Wilkins. 2004:601–603.
- Wendelien M. A study of the buffering capacity of the human rectum. Pharm Weekbl Scient Ed 1989; 11:9–12.
- American Heart Association (website): http://www.americanheart.org/presenter.jhtml?identifier=4753. Accessed 13 May 2010.
- Davies P, Levy S, Pahari A, Martinez D. Acute nicotine poisoning associated with a traditional remedy for eczema. Arch Dis Child 2001; 85:500–502.
- Moriya F, Hashimoto Y. A fatal poisoning caused by methomyl and nicotine. Forensic Sci Int 2005; 149:167–170.
- Houezec JL, Benowitz NL. Basic and clinical psychopharmacology of nicotine. Clin Chest Med 1991; 12:681–699.
- Gupta VK. Antimigraine action of nicotine: theoretical basis and potential clinical application. Eur J Emerg Med 2007; 14:243–244.